Edwin Rock, Chief Medical Officer at GLYCOMIMETICS INC (GLYC), bought 65,403 shares at $1.38 ($90K) on 2023-09-22, disclosed to the SEC on 2023-09-25.
Open-market purchase of $90k GLYC by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.38 | 35,000 | $48K | 53.5% |
| 2 | $1.38 | 30,403 | $42K | 46.5% |
| Total | $1.38 avg | 65,403 | $90K | 100% |
| Filing → |
| GLYC | BUY | 2022-11-16 | $309K | — | Filing → |